tm
Seeing Is Believing
tm
Seeing Is Believing
MLYS is currently covered by 2 analysts with an average price target of $46.89. This is a potential upside of $9.79 (26.39%) from yesterday's end of day stock price of $37.1.
Mineralys Therapeutics, Common Stock's activity chart (see below) currently has 6 price targets and 15 ratings on display. The stock rating distribution of MLYS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 66.96% with an average time for these price targets to be met of 485.5 days.
Highest price target for MLYS is $52, Lowest price target is $42, average price target is $47.
Most recent stock forecast was given by RICHARD LAW from GOLDMAN SACHS on 09-Sep-2025. First documented stock forecast 07-Mar-2023.
Currently out of the existing stock ratings of MLYS, 11 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$52
$14.9 (40.16%)
$24
4 days ago
(09-Sep-2025)
5/7 (71.43%)
$13.5 (35.06%)
648
Buy
$42
$4.9 (13.21%)
$42
5 days ago
(08-Sep-2025)
5/8 (62.5%)
$6.07 (16.89%)
323
What is MLYS (Mineralys Therapeutics, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on MLYS (Mineralys Therapeutics, Common Stock) with a proven track record?
Which analyst has the current lower performing score on MLYS (Mineralys Therapeutics, Common Stock) with a proven track record?
Which analyst has the most public recommendations on MLYS (Mineralys Therapeutics, Common Stock)?
Which analyst is the currently most bullish on MLYS (Mineralys Therapeutics, Common Stock)?
Which analyst is the currently most reserved on MLYS (Mineralys Therapeutics, Common Stock)?
